Maintenance treatment with rituximab in follicular NHL.

被引：0
|
作者：
Rubio-Martinez, Araceli [1 ]
Recasens, Valle [1 ]
Giraldo, Pilar [1 ]
机构：
[1] Miguel Servet Univ Hosp, Dept Hematol, Zaragoza, Spain
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4702
引用
收藏
页码：258B / 258B
页数：1
相关论文
共 50 条
  • [1] What is the role of maintenance rituximab in follicular NHL?
    Maloney, David G.
    ONCOLOGY-NEW YORK, 2008, 22 (01): : 20 - 26
  • [2] FOLLICULAR NHL IN TREATMENT WITH R-CHOP AND RITUXIMAB FOR MAINTENANCE, OUR EXPERIENCE
    Nadal Paula, Ortega
    Jose David, Gonzalez San Miguel
    Khoury Cristina, Romero
    Mesa Susej, Guedes
    Maria del Carmen, Losada Castillo
    Martin Manuel, Tapia
    Fuertes Fernando, Fernandez
    Quintana Cristina, Lemes
    Ruiz Ylenia, Morales
    Jose Miguel, Bosch Benitez
    Gomez Mar, Caballero
    HAEMATOLOGICA, 2021, 106 (10) : 297 - 298
  • [3] What is the role of maintenance rituximab in follicular NHL? The Maloney article reviewed
    Hainsworth, John D.
    ONCOLOGY-NEW YORK, 2008, 22 (01): : 26 - +
  • [4] Rituximab for ocular NHL.: Report of 2 cases.
    Desablens, B
    Benabid, L
    Salle, V
    Tabuteau, S
    Garidi, R
    Vaida, I
    Traullé, C
    Turut, P
    BLOOD, 2002, 100 (11) : 315B - 315B
  • [5] Rituximab maintenance treatment in follicular lymphoma
    不详
    EJHP PRACTICE, 2011, 17 (01): : 15 - 15
  • [6] The role of rituximab maintenance treatment in relapsed follicular NHL: An interim analysis of the EORTC randomized intergroup trial
    Hagenbeek, A
    Van Glabbeke, M
    Teodorovic, I
    Rozewicz, C
    Klasa, R
    Marcus, RE
    Wolf, M
    Kimby, E
    van Oers, MHJ
    ANNALS OF ONCOLOGY, 2005, 16 : 52 - 52
  • [7] Final results of a phase II study to evaluate the efficacy and safety of treatment and retreatment with rituximab in relapsed follicular or low-grade NHL.
    López, A
    Palacios, C
    Pérez-Manga, G
    Flores, E
    Funes, HC
    de la Serna, J
    Moreno, JA
    Bernabé, R
    Murias, A
    López, JJ
    Rueda, A
    Pérez, V
    BLOOD, 2001, 98 (11) : 604A - 604A
  • [8] Rituximab:: Phase II (PII) retreatment (ReRx) study in patients (pts) with low-grade or follicular (LG/F) NHL.
    Davis, T
    Levy, R
    White, CA
    Czuczman, M
    McLaughlin, P
    Link, B
    Varns, C
    Weaver, R
    Grillo-López, AJ
    BLOOD, 1998, 92 (10) : 414A - 414A
  • [9] A cost utility analysis of maintenance rituximab for the treatment of relapsed/refractory follicular non hodgkins lymphoma (NHL) in the United Kingdom
    Geary, U.
    Lewis, G.
    Aultman, R.
    Aristides, M.
    VALUE IN HEALTH, 2007, 10 (06) : A336 - A337
  • [10] Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL
    Heizmann, M
    Itin, P
    Wernli, M
    Borradori, L
    Bargetzi, MJ
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 66 (02) : 142 - 144
12345